Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,131.00
+3.80 (0.34%)
May 13, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 117.92 billion as of May 13, 2026. Its market cap has decreased by -32.85% in one year.
Market Cap
117.92B
Enterprise Value
114.62B
Revenue
11.59B
Ranking
n/a
PE Ratio
37.97
Stock Price
1,131.00
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 117.92B, an increase of 19.56%. That is a compound annual growth rate of 6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 117.92B | -16.23% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 651.31B |
| Anthem Biosciences | 448.75B |
| OneSource Specialty Pharma | 205.19B |
| Blue Jet Healthcare | 77.30B |
| Supriya Lifescience | 55.04B |
| Zota Health Care | 40.33B |
| Dishman Carbogen Amcis | 27.41B |
| Panacea Biotec | 23.96B |